University of Chicago Hematology/Oncology
@UChicagoHemOnc
UChicago's Section of Hematology/Oncology has a long tradition of excellence and is ranked among the finest cancer programs in the country.
Our "Explain Cancer to Me" comic on clinical trials is officially available in 11 languages!! English, Spanish, Polish, Arabic, Mandarin (both simplified and traditional), Hindi, Urdu, Tagalog, Polish, French, & Haitian Creole can all be found at voices.uchicago.edu/communitycance…
Save the date! 🗓️ This year's #JonasCenterSymposium on cellular therapy will be September 26 here on the @UChicago campus! Learn more/register at jonascentersymposium.com
New article alert! 🚨🚨 Dr. @Anand_88_Patel and 3rd year @UCHemOncFellows Dr. Yates are published in @Haematologica sharing the results of the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)! haematologica.org/article/view/1…
🚨 Our faculty in the media!! 🚨 Dr. @SoniSmithMD on @Medscape weighing in on the #DLBCL debate: medscape.com/viewarticle/dl… and Dr. Kindler on @medpagetoday talking about surgery in #mesothelioma medpagetoday.com/reading-room/a… ‼️
🎥 Andrzej Jakubowiak shares his insights on multiple myeloma updates EHA2025. -> medicaldigest.org/scientific-con… @UChicagoHemOnc @UChicagoMed @EHA_Hematology
Summer is the perfect time to learn more about sun safety and skin cancer prevention! Join today from 12-2!!
Congratulations, Dr. @Anand_88_Patel!!!
a huge congratulations to @Anand_88_Patel for being selected for a @theNCI Early Career Investigator Award! @UCCancerCenter @UChicagoHemOnc reporter.nih.gov/search/5QB1uxC…
🔥 Hot off the press: In a new study, Cooperrider et al., show that lenalidomide drives expansion of high-risk TP53-mutant clones, which may predispose MM patients to secondary blood cancers like t-MDS and t-ALL. @CanerSaygin @bdermanmd @UChicagoHemOnc ow.ly/gvMO50WqIjj
A new Medical Stories segment is out/airing on @PBS featuring Dr. @AriRosenbergMD & one of his patients (who is also a former @UChicago employee!!). It's a beautiful episode & definitely worth a watch! You can find it at medicalstories.tv/title/head-and… #HeadNeckCancer #AtTheForefront
Welcome 🎉 We're so glad you're all here!!
We were thrilled to welcome our incoming first-year fellows to the program earlier this week. Orientation is officially complete ✅. Here’s to a year of growth, learning, and meaningful impact—let the adventure begin! @UChicagoHemOnc @UCCancerCenter @HemOncFellows
Thrilled to share our recent team science article unraveling TAM heterogeneity across PC disease spectrum & therapeutic targeting of "bad actor" SPP1+/TREM2+ TAM subsets in mCRPC: aacrjournals.org/mcr/article-ab… @PCF_Science @UChicagoHemOnc @UCCancerCenter @UChicagoCCB @TheVFoundation
Welcome to our new @UCHemOncFellows Chief Fellow, Dr. Abodunrin!! We can't wait to see what you do this year! 🎉
Our faculty in the media!! Dr. Olson on @ASCO Daily News talking about treatment & delivery of care in PD-1–Refractory Melanoma (dailynews.ascopubs.org/do/emerging-tr…) & coverage of Dr. @marinagarassino 's talk at ESMO on the MARIPOSA trial on @OncologyTimes (journals.lww.com/oncology-times…)!!
'Counting days to welcoming our incoming first-year fellows. @UChicagoHemOnc
We're very excited to announce our class of incoming Hem/Onc fellows, the class of 2028! @UChicagoHemOnc
Thank you to our outgoing @UCHemOncFellows Chief Fellow, Dr. @AlexandraRojek!! You have made such an impact this year!!
🚨Our team in the media!! 🚨 @UCHemOncFellows Dr. Haque in @BeckersHR talking about globalizing clinical trials (beckershospitalreview.com/oncology/globa…) & Section Chief Dr. @SoniSmithMD on @GoHealio talking about new treatment options for lymphoma (healio.com/news/hematolog…)!! #AtTheForefront
An important new piece by Dr. Ratain was published recently in @TheCancerLetter about dose optimization, a topic on which he is an expert & advocate! Read it at cancerletter.com/trials-and-tri…!!
Our clinical trials infrastructure extends to our network sites too! For Part 3 of our "Day in the Life of a CRC" video, we hear from two team members who are part our network teams! #ClinicalTrialsAwareness #CancerResearch
A new article out first-authored by 3rd year @UCHemOncFellows Dr. Madero-Marroquin/senior-authored by Dr. @Anand_88_Patel (featuring many of our faculty & trainees and co-authors!) in @e_jHaem about a new treatment progression for AML & MDS!! Read it at onlinelibrary.wiley.com/doi/10.1002/jh…
Our faculty in the media!! Dr. Shergill is on @EverydayHealth talking about the rise in appendix cancer in GenX/millenial groups-- part of the rising rates of cancer diagnoses in young people. Learn more from Dr. Shergill at everydayhealth.com/cancer/appendi…